Ann: Notice of Annual General Meeting/Proxy Form, page-29

I agree that a new company name befitting the new identity is a good thing.

But is anyone concerned that it is too close to the name of an existing ASX company - Neurizer:NRZ. And also Neuren:NEU.

As @kpax pointed out, Neurizon Therapeutics is already known as a part of a Swiss company - Neurizon Pharma.

I believe the new company name should be a unique identifier not to be confused with any other organisation.

We already own Pitney Pharmaceuticals. How about we name the new company Pitney NeuroTherapeutics?

I know it sounds rather bland, but it is simple, easily spelled and pronounced, and synthesises the two arms of the company.

Any thoughts?